General Information of Drug Off-Target (DOT) (ID: OT5AM0BM)

DOT Name Peroxisome assembly protein 26 (PEX26)
Synonyms Peroxin-26
Gene Name PEX26
Related Disease
Adrenoleukodystrophy ( )
Adrenomyeloneuropathy ( )
Peroxisome biogenesis disorder ( )
Peroxisome biogenesis disorder 1A (Zellweger) ( )
Peroxisome biogenesis disorder 7B ( )
Atrial fibrillation ( )
Peroxisome biogenesis disorder 1B ( )
Peroxisome biogenesis disorder 7A (Zellweger) ( )
Amelogenesis imperfecta ( )
Dental enamel hypoplasia ( )
Zellweger spectrum disorders ( )
UniProt ID
PEX26_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF07163
Sequence
MKSDSSTSAAPLRGLGGPLRSSEPVRAVPARAPAVDLLEEAADLLVVHLDFRAALETCER
AWQSLANHAVAEEPAGTSLEVKCSLCVVGIQALAEMDRWQEVLSWVLQYYQVPEKLPPKV
LELCILLYSKMQEPGAVLDVVGAWLQDPANQNLPEYGALAEFHVQRVLLPLGCLSEAEEL
VVGSAAFGEERRLDVLQAIHTARQQQKQEHSGSEEAQKPNLEGSVSHKFLSLPMLVRQLW
DSAVSHFFSLPFKKSLLAALILCLLVVRFDPASPSSLHFLYKLAQLFRWIRKAAFSRLYQ
LRIRD
Function
Peroxisomal docking factor that anchors PEX1 and PEX6 to peroxisome membranes. PEX26 is therefore required for the formation of the PEX1-PEX6 AAA ATPase complex, a complex that mediates the extraction of the PEX5 receptor from peroxisomal membrane.
Tissue Specificity Widely expressed . Highly expressed in kidney, liver, brain and skeletal muscles . Expressed at intermediate level in pancreas, placenta and heart . Weakly expressed in lung .
KEGG Pathway
Peroxisome (hsa04146 )
Reactome Pathway
Class I peroxisomal membrane protein import (R-HSA-9603798 )
Peroxisomal protein import (R-HSA-9033241 )

Molecular Interaction Atlas (MIA) of This DOT

11 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Adrenoleukodystrophy DISTUD1F Definitive Biomarker [1]
Adrenomyeloneuropathy DISPTS3P Definitive Biomarker [1]
Peroxisome biogenesis disorder DISBQ6QJ Definitive Autosomal recessive [2]
Peroxisome biogenesis disorder 1A (Zellweger) DISDO833 Definitive Autosomal recessive [1]
Peroxisome biogenesis disorder 7B DISKM7VC Definitive Autosomal recessive [3]
Atrial fibrillation DIS15W6U Strong Genetic Variation [4]
Peroxisome biogenesis disorder 1B DISCYF3O Strong Genetic Variation [5]
Peroxisome biogenesis disorder 7A (Zellweger) DISM5CI9 Strong Autosomal recessive [1]
Amelogenesis imperfecta DISGYR9E moderate Biomarker [6]
Dental enamel hypoplasia DISN6ZMR moderate Biomarker [6]
Zellweger spectrum disorders DISW52CE Supportive Autosomal recessive [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Peroxisome assembly protein 26 (PEX26). [8]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Peroxisome assembly protein 26 (PEX26). [9]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Peroxisome assembly protein 26 (PEX26). [11]
Trichostatin A DM9C8NX Investigative Trichostatin A affects the expression of Peroxisome assembly protein 26 (PEX26). [12]
Milchsaure DM462BT Investigative Milchsaure increases the expression of Peroxisome assembly protein 26 (PEX26). [13]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Peroxisome assembly protein 26 (PEX26). [10]
Glyphosate DM0AFY7 Investigative Glyphosate affects the methylation of Peroxisome assembly protein 26 (PEX26). [14]
------------------------------------------------------------------------------------

References

1 Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation. Am J Hum Genet. 2003 Aug;73(2):233-46. doi: 10.1086/377004. Epub 2003 Jul 8.
2 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
3 Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP. Nat Commun. 2019 May 30;10(1):2373. doi: 10.1038/s41467-019-10016-3.
4 Multi-ethnic genome-wide association study for atrial fibrillation.Nat Genet. 2018 Jun 11;50(9):1225-1233. doi: 10.1038/s41588-018-0133-9.
5 Mutations in the peroxin Pex26p responsible for peroxisome biogenesis disorders of complementation group 8 impair its stability, peroxisomal localization, and interaction with the Pex1p x Pex6p complex.J Biol Chem. 2006 Jan 20;281(3):1317-23. doi: 10.1074/jbc.M510044200. Epub 2005 Oct 27.
6 Next-generation sequencing reveals the mutational landscape of clinically diagnosed Usher syndrome: copy number variations, phenocopies, a predominant target for translational read-through, and PEX26 mutated in Heimler syndrome.Mol Genet Genomic Med. 2017 Jul 6;5(5):531-552. doi: 10.1002/mgg3.312. eCollection 2017 Sep.
7 Zellweger Spectrum Disorder. 2003 Dec 12 [updated 2020 Oct 29]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(?) [Internet]. Seattle (WA): University of Washington, Seattle; 1993C2024.
8 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
9 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
10 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
11 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
12 A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. PLoS One. 2017 May 25;12(5):e0178302. doi: 10.1371/journal.pone.0178302. eCollection 2017.
13 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
14 Association of Glyphosate Exposure with Blood DNA Methylation in a Cross-Sectional Study of Postmenopausal Women. Environ Health Perspect. 2022 Apr;130(4):47001. doi: 10.1289/EHP10174. Epub 2022 Apr 4.